Skip to content

Jones Hill Capital LP

Follow

13F filer, CIK 2102314, NEW YORK, NY

Jones Hill Capital LP reported $589,169,587 across 33 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13. Its ten largest share positions make up 68.09% of the portfolio.

Accepted , ingested 13F-HR 0002102314-26-000006

Period
2026-09-30
Reported value
$589M
Holdings
33
Top 10 weight
68.09%
New
19
Sold out
15

Largest buys vs the previous quarter

SecurityShares changeApprox. value
BCRXnew+7,083,300$59M
TVTXnew+959,634$56.5M
INDVnew+1,526,685$54.7M
CELCnew+382,901$30.4M
IONSnew+599,826$26.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
GILDexited-343,043-$43.3M
ARQTexited-1,089,701-$28.6M
MDGLexited-52,545-$28.2M
XENEexited-367,900-$22.2M
ANIPexited-233,808-$19.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0002102314-26-000006, largest first. % of portfolio is the value over $589,169,587, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: 1,268,390 shares; 2026Q2: 1,431,590 shares; 2026Q3: 1,171,859 shares 1,171,859$70.3M11.93%-259,731Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 7,083,300 shares 7,083,300$59M10.01%newTimeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 959,634 shares 959,634$56.5M9.59%newTimeline
INDVINDIVIOR PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,526,685 shares 1,526,685$54.7M9.29%newTimeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: 167,014 shares; 2026Q2: 677,879 shares; 2026Q3: 987,637 shares 987,637$31.3M5.32%+309,758Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 382,901 shares 382,901$30.4M5.17%newTimeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 599,826 shares 599,826$26.8M4.55%newTimeline
SUPNSUPERNUS PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 601,685 shares 601,685$25.9M4.4%newTimeline
NUVBNUVATION BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: 2,383,031 shares; 2026Q2: not reported; 2026Q3: 4,486,986 shares 4,486,986$25.1M4.26%newTimeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 652,218 shares 652,218$21.1M3.57%newTimeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: 370,175 shares; 2026Q2: 1,339,212 shares; 2026Q3: 1,447,156 shares 1,447,156$20.7M3.52%+107,944Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: 1,260,136 shares; 2026Q2: 892,621 shares; 2026Q3: 1,064,233 shares 1,064,233$19.8M3.36%+171,612Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: 342,752 shares; 2026Q2: 3,655,075 shares; 2026Q3: 5,237,628 shares 5,237,628$19.7M3.35%+1,582,553Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 142,558 shares 142,558$14.1M2.4%newTimeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: 1,759,492 shares; 2026Q3: 2,504,651 shares 2,504,651$13.2M2.24%+745,159Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: 122,375 shares; 2026Q3: 106,528 shares 106,528$12.2M2.06%-15,847Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 83,426 shares 83,426$11.8M2.01%newTimeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: 512,856 shares; 2026Q3: 384,278 shares 384,278$11.6M1.98%-128,578Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 610,118 shares 610,118$8.94M1.52%newTimeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: 909,207 shares; 2026Q2: 420,751 shares; 2026Q3: 892,532 shares 892,532$8.45M1.43%+471,781Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: 57,100 shares; 2026Q3: 80,017 shares 80,017$7.05M1.2%+22,917Timeline
NGNENEUROGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 217,700 shares 217,700$6.06M1.03%newTimeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: 653,572 shares; 2026Q3: 886,428 shares 886,428$6.05M1.03%+232,856Timeline
TNXPTONIX PHARMACEUTICALS HLDG CQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: 452,116 shares; 2026Q2: 625,428 shares; 2026Q3: 563,739 shares 563,739$5.49M0.93%-61,689Timeline
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 502,587 shares 502,587$4.97M0.84%newTimeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,900 shares 300,900$4.85M0.82%newTimeline
AVLNAVALYN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 126,744 shares 126,744$3.61M0.61%newTimeline
ATTOATTOVIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 182,295 shares 182,295$3.12M0.53%newTimeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: 161,486 shares; 2026Q3: 276,830 shares 276,830$2.02M0.34%+115,344Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 593,737 shares 593,737$2.01M0.34%newTimeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: 574,166 shares; 2026Q3: 206,397 shares 206,397$1.78M0.3%-367,769Timeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 122,169 shares 122,169$231K0.04%newTimeline
ALVOALVOTECHQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not loaded; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 26,700 shares 26,700$155K0.03%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
GILDGILEAD SCIENCES INC343,043$43.3Mshares
ARQTARCUTIS BIOTHERAPEUTICS INC1,089,701$28.6Mshares
MDGLMADRIGAL PHARMACEUTICALS INC52,545$28.2Mshares
XENEXENON PHARMACEUTICALS INC367,900$22.2Mshares
ANIPANI PHARMACEUTICALS INC233,808$19.4Mshares
AMLXAMYLYX PHARMACEUTICALS INC894,058$16.1Mshares
NUVLNUVALENT INC98,442$12.2Mshares
IMUXIMMUNIC INC539,814$8.3Mshares
ORICORIC PHARMACEUTICALS INC747,313$8.09Mshares
SNDXSYNDAX PHARMACEUTICALS INC340,000$7.43Mshares
VIRVIR BIOTECHNOLOGY INC659,213$6.72Mshares
VRTXVERTEX PHARMACEUTICALS INC11,123$5.53Mshares
ELVNENLIVEN THERAPEUTICS INC49,850$2.53Mshares
GPCRSTRUCTURE THERAPEUTICS INC40,567$2.18Mshares
ACHVACHIEVE LIFE SCIENCE INC26,760$175Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0002102314-26-000006 base2026-11-13